Eric Venker - 30 Jul 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
President & Immunovant CEO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Issuer symbol
ROIV
Transactions as of
30 Jul 2025
Transactions value $
$0
Form type
4
Filing time
01 Aug 2025, 21:09:54 UTC
Previous filing
30 Jul 2025
Next filing
22 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Venker Eric President & Immunovant CEO C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker 01 Aug 2025 0001801917

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +198K +13.57% $0.00 1.66M 30 Jul 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of restricted stock units with respect to Common Shares ("RSUs"), with a vesting commencement date of May 20, 2025, which service-vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through each vesting date.